Sage Journals: Discover world-class research

Open access

Research article

First published 2019

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β 2 -agonist fixed-dose combinations in COPD

Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins [...]

Therapeutic Advances in Respiratory Disease

Free access

Review article

First published 2012-12

The potential for aclidinium bromide,a new anticholinergic,in the management of chronic obstructive pulmonary disease

François Maltais, Julie Milot

Therapeutic Advances in Respiratory Disease

Free access

Review article

First published 2017-4

Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy

Kesavan Suresh Babu, Jaymin Bhagwanji Morjaria

Sage Open Chronic Disease

Retricted access

Research article

First published 2018-09

Asthma Guidelines Priority Topic: Long-Acting Anti-Muscarinic Agents in Asthma Management as Add-On to Inhaled Corticosteroids

Kathryn V. Blake, Hengameh H. Raissy

Pediatric Allergy,Immunology,and Pulmonology

Retricted access

Review article

First published 2017-8

Role of Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Therapy in Chronic Obstructive Pulmonary Disease

Sarah E. Petite

Annals of Pharmacotherapy

Free access

Review article

First published 2011-6

NVA237,a long-acting muscarinic antagonist,as an emerging therapy for chronic obstructive pulmonary disease

Claus Vogelmeier, Donald Banerji

Therapeutic Advances in Respiratory Disease

Free access

Review article

First published 2014-3

Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases

Khuder Alagha, Alain Palot, Tunde Sofalvi [...]

Sage Open Chronic Disease

Open access

Review article

First published 2023

Stepwise management of COPD: What is next after bronchodilation?

Marc Miravitlles, Kazuto Matsunaga, Michael Dreher

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2018

Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate,umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects

Mario Malerba, Matteo Nardin, Giuseppe Santini [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2013

Pharmacotherapies for COPD

Stan Ejiofor, Alice M. Turner

Therapeutic Advances in Pulmonary and Critical Care Medicine

Search results